Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Abstract Background There is emerging evidence for enhanced blood coagulation in coronavirus 2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and mortality. The mechanisms underlying this prothrombotic state remain enigmatic. Further data to guide anticoagulation...

Full description

Bibliographic Details
Main Authors: Jan Matthias Kruse, Abakar Magomedov, Annika Kurreck, Frédéric H. Münch, Roland Koerner, Julian Kamhieh-Milz, Andreas Kahl, Inka Gotthardt, Sophie K. Piper, Kai-Uwe Eckardt, Thomas Dörner, Daniel Zickler
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Critical Care
Subjects:
COVID-19
Coagulopathy
Hypofibrinolysis
ROTEM
D-dimers
Online Access:https://doi.org/10.1186/s13054-020-03401-8

Internet

https://doi.org/10.1186/s13054-020-03401-8

Similar Items